Loading...
 

Volume 33, Issue 2, June 2022



Sign in to download the Issue in PDF format.

Mediterr J Rheumatol 2022;33(2):237-40
Canakinumab might be Protective against Severe COVID-19 for Patients with Autoinflammatory Disorders
Authors Information

1Cerrahpasa Medical Faculty, University of Istanbul-Cerrahpasa, Istanbul, Turkey

2Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul-Cerrahpasa, Istanbul, Turkey

S Ugurlu

Abstract
This paper has no abstract.

Cite this article as: Alkan A, Ugurlu S. Canakinumab might be Protective against Severe COVID-19 for Patients with Autoinflammatory Disorders. Mediterr J Rheumatol 2022;33(2):237-40.

Article Submitted: 8 Feb 2021; Revised Form: 1 Sep 2021; Article Accepted: 30 Sep 2021; Available Online: 30 Jun 2022

https://doi.org/10.31138/mjr.33.2.237

This work is licensed under a Creative Commons Attribution 4.0 International License.

©Alkan A, Ugurlu S.